Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA: 688192)
China flag China · Delayed Price · Currency is CNY
46.18
-1.56 (-3.27%)
Nov 13, 2024, 9:30 AM CST

Dizal (Jiangsu) Pharmaceutical Revenue

Dizal (Jiangsu) Pharmaceutical had revenue of 134.90M CNY in the quarter ending September 30, 2024, with 236.39% growth. This brings the company's revenue in the last twelve months to 389.64M, up 871.61% year-over-year. In the year 2023, Dizal (Jiangsu) Pharmaceutical had annual revenue of 91.29M.

Revenue (ttm)
389.64M
Revenue Growth
+871.61%
P/S Ratio
48.74
Revenue / Employee
482.82K
Employees
581
Market Cap
19.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202391.29M--
Dec 31, 2022---
Dec 31, 202110.29M-17.48M-62.95%
Dec 31, 202027.76M-13.26M-32.32%
Dec 31, 201941.02M1.60M4.05%
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition